153 related articles for article (PubMed ID: 814098)
1. Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.
Youmans AS; Youmans GP; Cahall D
Infect Immun; 1976 Jan; 13(1):127-32. PubMed ID: 814098
[TBL] [Abstract][Full Text] [Related]
2. Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.
Neiburger RG; Youmans GP; Youmans AS
Infect Immun; 1973 Jul; 8(1):42-7. PubMed ID: 4198103
[TBL] [Abstract][Full Text] [Related]
3. Effect of metabolic inhibitors on the formation of antibody to sheep erythrocytes, on development of delayed hypersensitivity, and on the immune response to infection with Mycobacterium tuberculosis in mice.
Youmans AS; Youmans GP
Infect Immun; 1978 Jan; 19(1):212-6. PubMed ID: 415003
[TBL] [Abstract][Full Text] [Related]
4. The adjuvant activity of mycobacterial RNA preparations and synthetic polynucleotides for induction of delayed hypersensitivity to purified protein derivative in guinea pigs.
Casavant CH; Youmans GP
J Immunol; 1975 Mar; 114(3):1014-22. PubMed ID: 803534
[TBL] [Abstract][Full Text] [Related]
5. Effect of rifampin on cutaneous hypersensitivity to purified protein derivative in humans.
Mukerjee P; Schuldt S; Kasik JE
Antimicrob Agents Chemother; 1973 Dec; 4(6):607-11. PubMed ID: 4793880
[TBL] [Abstract][Full Text] [Related]
6. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.
Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W
Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressant activity of the ansamycins.
Kasik JE; Monick M; Thompson JS
Antimicrob Agents Chemother; 1976 Mar; 9(3):470-3. PubMed ID: 4011
[TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
[TBL] [Abstract][Full Text] [Related]
9. Allergenicity of mycobacterial ribosomal and ribonucleic acid preparations in mice and guinea pigs.
Youmans GP; Youmans AS
J Bacteriol; 1969 Jan; 97(1):134-9. PubMed ID: 4236903
[TBL] [Abstract][Full Text] [Related]
10. [Testing post-vaccination and post-infection hypersensitivity with the use of tuberculin PPD-S BCG Polska. I. Use of tuberculin PPD-S BCG in children vaccinated with BCG vaccine].
Krzyszkowska A; Rzucidło L; Zelechowska M; Wasowska J; Firko-Stepniewska O; Górski S; Szumilak I
Pneumonol Pol; 1982 Nov; 50(11):599-607. PubMed ID: 7182815
[No Abstract] [Full Text] [Related]
11. Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection.
Pais TF; Silva RA; Smedegaard B; Appelberg R; Andersen P
Immunology; 1998 Sep; 95(1):69-75. PubMed ID: 9767459
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine.
Gorak-Stolinska P; Weir RE; Floyd S; Lalor MK; Stenson S; Branson K; Blitz R; Luke S; Nazareth B; Ben-Smith A; Fine PE; Dockrell HM
Vaccine; 2006 Jul; 24(29-30):5726-33. PubMed ID: 16723176
[TBL] [Abstract][Full Text] [Related]
13. Comparative cutaneous testing with purified protein derivative and the antigen complex A60 in vaccinated subjects and tuberculosis patients.
Zou YL; Zhang JD; Chen MH; Shi GQ; Cocito C
Med Microbiol Immunol; 1995 May; 184(1):9-15. PubMed ID: 8538579
[TBL] [Abstract][Full Text] [Related]
14. The significance of a dual skin test with PPD and PPD-B in humans after BCG vaccination.
Landi S; Ashley MJ
Dev Biol Stand; 1986; 58 ( Pt B)():631-6. PubMed ID: 3111907
[TBL] [Abstract][Full Text] [Related]
15. Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis.
McMurray DN; Mintzer CL; Bartow RA; Parr RL
Infect Immun; 1989 Sep; 57(9):2606-11. PubMed ID: 2788135
[TBL] [Abstract][Full Text] [Related]
16. [Research on the immunosuppressive activity of rifampicin].
Pozzi E
Ann Sclavo; 1976; 18(5):755-62. PubMed ID: 829306
[TBL] [Abstract][Full Text] [Related]
17. Properties of TAS-1D3, a tuberculin-active substance from BCG, in regard to delayed hypersensitivity.
Yano O; Toizumi S; Sudo T
Microbiol Immunol; 1984; 28(10):1149-57. PubMed ID: 6441106
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ
Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218
[TBL] [Abstract][Full Text] [Related]
19. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
Black GF; Weir RE; Floyd S; Bliss L; Warndorff DK; Crampin AC; Ngwira B; Sichali L; Nazareth B; Blackwell JM; Branson K; Chaguluka SD; Donovan L; Jarman E; King E; Fine PE; Dockrell HM
Lancet; 2002 Apr; 359(9315):1393-401. PubMed ID: 11978337
[TBL] [Abstract][Full Text] [Related]
20. BCG vaccination in India and tuberculosis in children: newer facets.
Udani PM
Indian J Pediatr; 1994; 61(5):451-62. PubMed ID: 7744445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
